273 related articles for article (PubMed ID: 36125128)
1. LATS1/2 control TGFB-directed epithelial-to-mesenchymal transition in the murine dorsal cranial neuroepithelium through YAP regulation.
Martínez Traverso IM; Steimle JD; Zhao X; Wang J; Martin JF
Development; 2022 Sep; 149(18):. PubMed ID: 36125128
[TBL] [Abstract][Full Text] [Related]
2. Hippo-Yap Signaling Maintains Sinoatrial Node Homeostasis.
Zheng M; Li RG; Song J; Zhao X; Tang L; Erhardt S; Chen W; Nguyen BH; Li X; Li M; Wang J; Evans SM; Christoffels VM; Li N; Wang J
Circulation; 2022 Nov; 146(22):1694-1711. PubMed ID: 36317529
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of Lats1 and Lats2 highlights the role of hippo pathway effector YAP in larynx and vocal fold epithelium morphogenesis.
Mohad V; Lungova V; Verheyden J; Thibeault SL
Dev Biol; 2021 May; 473():33-49. PubMed ID: 33515576
[TBL] [Abstract][Full Text] [Related]
4. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
5. Yap and Taz play a crucial role in neural crest-derived craniofacial development.
Wang J; Xiao Y; Hsu CW; Martinez-Traverso IM; Zhang M; Bai Y; Ishii M; Maxson RE; Olson EN; Dickinson ME; Wythe JD; Martin JF
Development; 2016 Feb; 143(3):504-15. PubMed ID: 26718006
[TBL] [Abstract][Full Text] [Related]
6. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
7.
Nantie LB; Young RE; Paltzer WG; Zhang Y; Johnson RL; Verheyden JM; Sun X
Development; 2018 Nov; 145(21):. PubMed ID: 30305289
[TBL] [Abstract][Full Text] [Related]
8.
Tsoi M; Morin M; Rico C; Johnson RL; Paquet M; Gévry N; Boerboom D
FASEB J; 2019 Oct; 33(10):10819-10832. PubMed ID: 31268774
[TBL] [Abstract][Full Text] [Related]
9. Lipid kinase PIP5Kα contributes to Hippo pathway activation via interaction with Merlin and by mediating plasma membrane targeting of LATS1.
Le TPH; Nguyen NTT; Le DDT; Anwar MA; Lee SY
Cell Commun Signal; 2023 Jun; 21(1):149. PubMed ID: 37337213
[TBL] [Abstract][Full Text] [Related]
10. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway.
Meng Z; Moroishi T; Mottier-Pavie V; Plouffe SW; Hansen CG; Hong AW; Park HW; Mo JS; Lu W; Lu S; Flores F; Yu FX; Halder G; Guan KL
Nat Commun; 2015 Oct; 6():8357. PubMed ID: 26437443
[TBL] [Abstract][Full Text] [Related]
11. WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy.
Qi S; Zhu Y; Liu X; Li P; Wang Y; Zeng Y; Yu A; Wang Y; Sha Z; Zhong Z; Zhu R; Yuan H; Ye D; Huang S; Ling C; Xu Y; Zhou D; Zhang L; Yu FX
Mol Cell; 2022 May; 82(10):1850-1864.e7. PubMed ID: 35429439
[TBL] [Abstract][Full Text] [Related]
12.
St-Jean G; Tsoi M; Abedini A; Levasseur A; Rico C; Morin M; Djordjevic B; Miinalainen I; Kaarteenaho R; Paquet M; Gévry N; Boyer A; Vanderhyden B; Boerboom D
Development; 2019 Oct; 146(20):. PubMed ID: 31575647
[TBL] [Abstract][Full Text] [Related]
13.
Li L; Dong L; Wang Y; Zhang X; Yan J
Biomed Res Int; 2018; 2018():4387932. PubMed ID: 30671453
[TBL] [Abstract][Full Text] [Related]
14. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-181c contributes to chemoresistance in pancreatic cancer by inactivating the Hippo signaling pathway.
Chen M; Wang M; Xu S; Guo X; Jiang J
Oncotarget; 2015 Dec; 6(42):44466-79. PubMed ID: 26561204
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway.
Zhu C; Ji X; Zhang H; Zhou Q; Cao X; Tang M; Si Y; Yan H; Li L; Liang T; Feng XH; Zhao B
J Biol Chem; 2018 Jan; 293(4):1178-1191. PubMed ID: 29183995
[TBL] [Abstract][Full Text] [Related]
17. Targeted Disruption of Lats1 and Lats2 in Mice Impairs Testis Development and Alters Somatic Cell Fate.
Abou Nader N; Ménard A; Levasseur A; St-Jean G; Boerboom D; Zamberlam G; Boyer A
Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362374
[TBL] [Abstract][Full Text] [Related]
18. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
19. LATS1/2 suppress NFκB and aberrant EMT initiation to permit pancreatic progenitor differentiation.
Braitsch CM; Azizoglu DB; Htike Y; Barlow HR; Schnell U; Chaney CP; Carroll TJ; Stanger BZ; Cleaver O
PLoS Biol; 2019 Jul; 17(7):e3000382. PubMed ID: 31323030
[TBL] [Abstract][Full Text] [Related]
20. Hippo Signaling Plays an Essential Role in Cell State Transitions during Cardiac Fibroblast Development.
Xiao Y; Hill MC; Zhang M; Martin TJ; Morikawa Y; Wang S; Moise AR; Wythe JD; Martin JF
Dev Cell; 2018 Apr; 45(2):153-169.e6. PubMed ID: 29689192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]